Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.

Buggert M, Frederiksen J, Lund O, Betts MR, Biague A, Nielsen M, Tauriainen J, Norrgren H, Medstrand P, Karlsson AC, Jansson M; SWEGUB CORE group..

AIDS. 2016 Oct 23;30(16):2415-2426.

2.

Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.

Bächle SM, Malone DF, Buggert M, Karlsson AC, Isberg PE, Biague AJ, Norrgren H, Medstrand P, Moll M, Sandberg JK, Jansson M; SWEGUB CORE group..

AIDS. 2016 Jul 17;30(11):1713-22. doi: 10.1097/QAD.0000000000001147.

3.

Predicting the extinction of HIV-2 in rural Guinea-Bissau.

Fryer HR, Van Tienen C, Van Der Loeff MS, Aaby P, Da Silva ZJ, Whittle H, Rowland-Jones SL, de Silva TI.

AIDS. 2015 Nov 28;29(18):2479-86. doi: 10.1097/QAD.0000000000000844.

4.

Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Gottlieb GS.

AIDS. 2013 Jan 2;27(1):135-7. doi: 10.1097/QAD.0b013e32835a11a4. No abstract available.

5.

Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

Heitzinger K, Sow PS, Dia Badiane NM, Gottlieb GS, N'Doye I, Toure M, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group..

Int J STD AIDS. 2012 Oct;23(10):710-6. doi: 10.1258/ijsa.2012.011219.

6.

Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.

Özkaya Şahin G, Holmgren B, Sheik-Khalil E, da Silva Z, Nielsen J, Nowroozalizadeh S, Månsson F, Norrgren H, Aaby P, Fenyö EM, Jansson M.

J Virol. 2013 Jan;87(1):273-81. doi: 10.1128/JVI.01640-12. Epub 2012 Oct 17.

7.

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Faria NR, Hodges-Mameletzis I, Silva JC, Rodés B, Erasmus S, Paolucci S, Ruelle J, Pieniazek D, Taveira N, Treviño A, Gonçalves MF, Jallow S, Xu L, Camacho RJ, Soriano V, Goubau P, de Sousa JD, Vandamme AM, Suchard MA, Lemey P.

J Gen Virol. 2012 Apr;93(Pt 4):889-99. doi: 10.1099/vir.0.038638-0. Epub 2011 Dec 21.

8.

Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Ozkaya Sahin G, Holmgren B, da Silva Z, Nielsen J, Nowroozalizadeh S, Esbjörnsson J, Månsson F, Andersson S, Norrgren H, Aaby P, Jansson M, Fenyö EM.

J Virol. 2012 Jan;86(2):961-71. doi: 10.1128/JVI.06315-11. Epub 2011 Nov 9.

9.

HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations.

Esbjörnsson J, Mild M, Månsson F, Norrgren H, Medstrand P.

PLoS One. 2011 Feb 18;6(2):e17025. doi: 10.1371/journal.pone.0017025.

10.

A network-individual-resource model for HIV prevention.

Johnson BT, Redding CA, DiClemente RJ, Mustanski BS, Dodge B, Sheeran P, Warren MR, Zimmerman RS, Fisher WA, Conner MT, Carey MP, Fisher JD, Stall RD, Fishbein M.

AIDS Behav. 2010 Dec;14(Suppl 2):204-21. doi: 10.1007/s10461-010-9803-z.

11.

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

van Tienen C, van der Loeff MF, Peterson I, Cotten M, Holmgren B, Andersson S, Vincent T, Sarge-Njie R, Rowland-Jones S, Jaye A, Aaby P, Whittle H.

Retrovirology. 2010 Jun 4;7:50. doi: 10.1186/1742-4690-7-50.

12.

Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Esbjörnsson J, Månsson F, Martínez-Arias W, Vincic E, Biague AJ, da Silva ZJ, Fenyö EM, Norrgren H, Medstrand P.

Retrovirology. 2010 Mar 22;7:23. doi: 10.1186/1742-4690-7-23.

Supplemental Content

Support Center